Purpose: To determine the prevalence of tamoxifen retinopathy and assess the utility of a screening protocol using non-mydriatic fundus photography and optical coherence tomography (OCT). Methods: Between May and October 2024, patients on tamoxifen therapy at a breast surgery clinic were offered screening including non-mydriatic fundus photography and OCT. Among those who consented, 290 patients (580 eyes) were included after excluding other retinal diseases. We investigated tamoxifen duration, cumulative dose, central retinal thickness, BMI, underlying diseases, menopausal status, and history of chemotherapy, hormone therapy, or oral contraceptives. Results: All patients were taking 20 mg of tamoxifen daily. The mean treatment duration was 55.7 ± 29.5 months for those treated longer than two years (n = 193), with a mean BMI of 22.1 ± 3.0 kg/m2. Systemic comorbidities included dyslipidemia (n = 27, 14.0%), hypertension (n = 19, 9.8%), diabetes mellitus (n = 13, 6.7%), and cardiovascular disease (n = 4, 2.1%). Additionally, patient histories included chemotherapy (n = 84, 43.7%), postmenopausal status (n = 56, 29.1%), hormone therapy (n = 52, 27.0%), and oral contraceptive use (n = 14, 7.2%). Tamoxifen retinopathy was not observed in any of the patients. Conclusions In this cross-sectional study, the prevalence of tamoxifen retinopathy, as assessed by non-mydriatic fundus photography and OCT in this study, was 0%, which is lower than previously reported rates (0.9%–12%). Although specialized examination by an ophthalmologist, including a dilated fundus examination and OCT remains the diagnostic gold standard, practical constraints can limit its routine clinical use. Our study evaluated a screening protocol performed without ophthalmologist intervention. However, we found that limitations in image quality compromised the detection of subtle lesions, such as crystalline deposits. Consequently, this approach may be insufficient to serve as a primary screening strategy.

Alzheimer’s disease (AD) is characterized by progressive cognitive deterioration and significant depression. However, the mechanisms linking depression to AD pathology remain unclear. Here, we investigated whether Notch2 signaling mediates depressionlike behaviors in presenilin-2 (PS2) N141I mutant mice, an early-onset AD model. PS2 wild-type (WT) and mutant (MT) mice aged 12-15 months were subjected to unpredictable chronic mild stress (UCMS) for 4 weeks, followed by sucrose preference, tail-hanging, and forced swimming tests. Behavioral assessments showed that UCMS exacerbated anhedonia and immobility only in PS2 MT mice. Molecular analysis revealed concomitant increases in plasma corticosterone, hippocampal γ-secretase activity, and Notch2 expression, and elevated total and phosphorylated glucocorticoid receptor levels in PS2 MT-UCMS mice. Gene expression profiling of human hippocampal datasets confirmed upregulation of NOTCH2 in Alzheimer’s disease and depression.Pharmacological inhibition of γ-secretase and Notch signaling with DAPT normalizes depressive behavior, reduces corticosterone release, attenuates GR phosphorylation, and inhibits Notch2 signaling in PS2 MT mice. These findings identify Notch2 as a pivotal mediator linking chronic stress to molecular changes associated with depression and AD, and suggest that targeting Notch2 signaling may provide therapeutic benefits for comorbid mood and neurodegenerative disorders.

Background: Studies on whether donor-to-recipient sex match status affects long-term survival after liver transplantation (LT) have yielded contradictory results. This study evaluated whether donor-to-recipient sex match status influenced long-term survival after living donor liver transplantation (LDLT) or deceased donor liver transplantation (DDLT) at a high-volume center. Methods: The study included 6,664 patients who underwent primary LT between January 2000 and December 2022 at our institution. Patients were divided into four groups according to donor-to-recipient sex match status: male-to-male (n=3,427 [51.4%]), male-to-female (n=1,152 [17.3%]), female-to-male (n=1,385 [20.8%]), and female-to-female (n=700 [10.5%]). Results: Regarding clinical characteristics, the four groups differed significantly regarding background liver disease (P<0.001), model for end-stage liver disease score (P<0.001), serum protein induced by vitamin K absence or antagonist II level (P=0.003), presence of concurrent hepatocellular carcinoma (HCC; P<0.001), and type of LT (P=0.003). Overall survival (OS) of all LT recipients did not differ significantly among the groups (P=0.377). Donor-to-recipient sex match status did not affect long-term OS in either LDLT (P=0.176) or DDLT (P=0.220) groups. In addition, sex match status did not significantly influence posttransplant OS among patients who underwent LDLT without HCC (P=0.464), LDLT with HCC (P=0.236), DDLT without HCC (P=0.338), or DDLT with HCC (P=0.818). Conclusions Donor-to-recipient sex match status does not significantly affect posttransplant patient survival or HCC prognosis after LDLT or DDLT.

Background: The accuracy-based creatinine (ABCr) proficiency testing (PT) program by the Korean Association of External Quality Assessment Service evaluates bias and acceptability in participating laboratories using target values assigned by the primary reference measurement procedure (RMP). This study evaluated the impact of type A standard measurement uncertainty (MU) in the primary RMP on bias and acceptability assessments. Methods: ABCr PT data from 2020 to 2021 were analyzed. Using the target mean, standard deviation, and number of replicates provided by the Reference Material Institute for Clinical Chemistry Standards laboratory (Japan), the type A MU for each sample was calculated using a bottom-up approach. Bias and acceptability of creatinine assays were compared with and without the inclusion of type A MU when assigning target values. Results: The type A MU of the primary RMP for the creatinine assays ranged from 0.01 to 0.02 mg/dL depending on the sample. Without type A MU, the mean bias of creatinine assay ranged from −2.9% to 6.5%. Incorporating type A MU into target values, adjusted the mean bias to −3.2% to 5.3% (with addition) and −2.6% to 7.8% (with subtraction). Acceptability rates ranged from 69.2% to 95.0% without type A MU and shifted to 70.1% to 95.1% (with addition) and 68.5% to 95.4% (with subtraction). Conclusions The inclusion of type A MU in the primary RMP affects bias and acceptability assessment, highlighting its significance in the interpretation of ABCr PT results.

This review examines the challenges associated with occupational disease surveillance in Korea, particularly emphasizing the limitations of current data sources such as the Industrial Accident Compensation Insurance (IACI) statistics and special health examinations. The IACI system undercounts cases due to its emphasis on severe diseases and restrictions on approvals. Special health examinations, although they cover a broad workforce, are constrained by their annual scheduling, which leads to missed acute illnesses and subclinical conditions. The paper also explores the history of occupational disease surveillance in Korea, highlighting the fragmented and disease-specific approach of earlier systems. The authors introduce the newly established Korea Occupational Disease Surveillance Center (KODSC), a comprehensive nationwide system designed to gather, analyze, and interpret data on occupational diseases through a network of regional centers. By incorporating hospital-based surveillance and focusing on acute poisonings and other sentinel events, the KODSC aims to overcome the limitations of previous systems and promote collaboration with various agencies. Although it is still in the early stages of implementation, the KODSC demonstrates potential for improving data accuracy and contributing valuable insights for public health policy.

Background: Syphilis, an infectious and chronic disease primarily transmitted through sexual contact, is caused by the spirochete bacterium Treponema pallidum. Although the introduction of penicillin has significantly reduced its incidence, syphilis continues to have a substantial impact on public health. Objective: The purpose of this study was to investigate trends in syphilis and to analyze its epidemiologic, clinical, and serologic characteristics. Methods: We retrospectively reviewed the medical records of 330 patients who tested positive for the Venereal Disease Research Laboratory (VDRL) test, including 192 patients who received a diagnosis of syphilis and who visited the Dermatology Department of Gachon University Gil Medical Center between 2000 and 2023. Statistical analyses were performed to evaluate trends in syphilis incidence and related variable factors, such as sex, age, and serological results. Results: The average age of the 192 syphilis patients was 34.18±15.81 years, with a male-to-female ratio of 1:1.2. The most prevalent age group was 20∼29 years, comprising 71 patients (37.0%). Over time, the incidence of syphilis demonstrated a decreasing trend (p＜0.001). A total of 105 patients (54.7%) were diagnosed with symptomatic syphilis, with a male-to-female ratio of 1.5:1. The proportion of symptomatic syphilis patients tended to decrease with increasing age (p＜0.05). Maculopapular syphilis was the most frequently observed presentation in secondary syphilis (36.2%). The proportion of symptomatic syphilis patients significantly increased with higher VDRL titers (p＜0.001). Conclusion The incidence of syphilis has shown a consistent decline over the past two decades. However, the relatively higher prevalence among younger age groups indicates the need for continued public health efforts.

Regorafenib is an oral multikinase inhibitor used to treat advanced solid tumors, including hepatocellular carcinoma (HCC), gastrointestinal stromal tumors, and colorectal cancer. Adverse dermatological reactions are common after regorafenib treatment. The most frequent cutaneous adverse reaction is hand-foot skin reaction (HFSR). Compared to HFSR, reports on adverse reactions on the scrotum associated with regorafenib are limited. Only a few cases of adverse reactions on the scrotum associated with HFSR have been reported. We present the case of a 55-year-old male patient with a 1-year history of scrotal dermatitis and HFSR, who had been undergoing treatment for HCC.One year after administration of oral regorafenib (160 mg/d), multiple vesicles, pustules, desquamation, and hyperkeratosis developed on both hands and feet, accompanied by scaly erythematous plaques around the scrotum.The lesions improved after two weeks of treatment with topical and systemic steroids. Herein, we report a rare case of scrotal dermatitis associated with regorafenib-induced HFSR.

This review examines the challenges associated with occupational disease surveillance in Korea, particularly emphasizing the limitations of current data sources such as the Industrial Accident Compensation Insurance (IACI) statistics and special health examinations. The IACI system undercounts cases due to its emphasis on severe diseases and restrictions on approvals. Special health examinations, although they cover a broad workforce, are constrained by their annual scheduling, which leads to missed acute illnesses and subclinical conditions. The paper also explores the history of occupational disease surveillance in Korea, highlighting the fragmented and disease-specific approach of earlier systems. The authors introduce the newly established Korea Occupational Disease Surveillance Center (KODSC), a comprehensive nationwide system designed to gather, analyze, and interpret data on occupational diseases through a network of regional centers. By incorporating hospital-based surveillance and focusing on acute poisonings and other sentinel events, the KODSC aims to overcome the limitations of previous systems and promote collaboration with various agencies. Although it is still in the early stages of implementation, the KODSC demonstrates potential for improving data accuracy and contributing valuable insights for public health policy.

Background: The accuracy-based creatinine (ABCr) proficiency testing (PT) program by the Korean Association of External Quality Assessment Service evaluates bias and acceptability in participating laboratories using target values assigned by the primary reference measurement procedure (RMP). This study evaluated the impact of type A standard measurement uncertainty (MU) in the primary RMP on bias and acceptability assessments. Methods: ABCr PT data from 2020 to 2021 were analyzed. Using the target mean, standard deviation, and number of replicates provided by the Reference Material Institute for Clinical Chemistry Standards laboratory (Japan), the type A MU for each sample was calculated using a bottom-up approach. Bias and acceptability of creatinine assays were compared with and without the inclusion of type A MU when assigning target values. Results: The type A MU of the primary RMP for the creatinine assays ranged from 0.01 to 0.02 mg/dL depending on the sample. Without type A MU, the mean bias of creatinine assay ranged from −2.9% to 6.5%. Incorporating type A MU into target values, adjusted the mean bias to −3.2% to 5.3% (with addition) and −2.6% to 7.8% (with subtraction). Acceptability rates ranged from 69.2% to 95.0% without type A MU and shifted to 70.1% to 95.1% (with addition) and 68.5% to 95.4% (with subtraction). Conclusions The inclusion of type A MU in the primary RMP affects bias and acceptability assessment, highlighting its significance in the interpretation of ABCr PT results.

Background: The accuracy-based creatinine (ABCr) proficiency testing (PT) program by the Korean Association of External Quality Assessment Service evaluates bias and acceptability in participating laboratories using target values assigned by the primary reference measurement procedure (RMP). This study evaluated the impact of type A standard measurement uncertainty (MU) in the primary RMP on bias and acceptability assessments. Methods: ABCr PT data from 2020 to 2021 were analyzed. Using the target mean, standard deviation, and number of replicates provided by the Reference Material Institute for Clinical Chemistry Standards laboratory (Japan), the type A MU for each sample was calculated using a bottom-up approach. Bias and acceptability of creatinine assays were compared with and without the inclusion of type A MU when assigning target values. Results: The type A MU of the primary RMP for the creatinine assays ranged from 0.01 to 0.02 mg/dL depending on the sample. Without type A MU, the mean bias of creatinine assay ranged from −2.9% to 6.5%. Incorporating type A MU into target values, adjusted the mean bias to −3.2% to 5.3% (with addition) and −2.6% to 7.8% (with subtraction). Acceptability rates ranged from 69.2% to 95.0% without type A MU and shifted to 70.1% to 95.1% (with addition) and 68.5% to 95.4% (with subtraction). Conclusions The inclusion of type A MU in the primary RMP affects bias and acceptability assessment, highlighting its significance in the interpretation of ABCr PT results.